abstract |
PCT No. PCT/US93/11155 Sec. 371 Date Jun. 2, 1995 Sec. 102(e) Date Jun. 2, 1995 PCT Filed Nov. 18, 1993 PCT Pub. No. WO94/14452 PCT Pub. Date Jul. 7, 1994The present invention is concerned with the use of 17 beta -N-monosubstituted-carbamaoyl-4-aza-5 alpha -androst-1-en-3-one compounds as testosterone-5 alpha -reductase inhibitors for the treatment of chronic prostatitis. |